Failure of a combination of two antifungal drugs, terbinafine plus itraconazole, in Sudanese post kala-azar dermal leishmaniasis.
Khalil
E A
EA
Institute of Endemic Diseases, University of Khartoum, Sudan.
Nur
N M
NM
Zijlstra
E E
EE
El-Hassan
A M
AM
Davidson
R N
RN
D000293:Adolescent; D000328:Adult; D000935:Antifungal Agents / Q000627:therapeutic use*; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D002648:Child; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D017964:Itraconazole / Q000627:therapeutic use*; D016773:Leishmaniasis, Cutaneous / Q000188:drug therapy* / Q000209:etiology; D007898:Leishmaniasis, Visceral / Q000150:complications*; D008297:Male; D009281:Naphthalenes / Q000627:therapeutic use*; D013397:Sudan; D000077291:Terbinafine; D017211:Treatment Failure; D014344:Trypanocidal Agents / Q000627:therapeutic use*
D000935:Antifungal Agents; D000981:Antiprotozoal Agents; D009281:Naphthalenes; D014344:Trypanocidal Agents; D017964:Itraconazole; D000077291:Terbinafine